Showing results (41-50 of 164) with videos related to
Sort By:
Pageof 17
Oncology Reports|May 19, 2011
Early detection of recurrent mono-metastases of breast cancer to endocrine tissues by following CEA levelsY Levy, J George, V Barak, et al.Clinical and Experimental Rheumatology|November 2, 1999
Cytokines in experimental autoimmune vasculitis: evidence for a Th2 type responseY Tomer, V Barak, B Gilburd, et al.Leukemia Research|August 1, 1996
Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantationA Nagler, I Shur, V Barak, et al.American Journal of Ophthalmology|January 1, 1993
Serum levels of interleukin-2 receptor in ocular Behçet's diseaseD BenEzra, G Maftzir, I Kalichman, et al.Journal of Hematotherapy|January 1, 1994
Treatment of chronic myelogenous leukemia with recombinant human interleukin-2 and interferon-alpha 2aA Nagler, A Ackerstein, V Barak, et al.Cytokines, Cellular & Molecular Therapy|November 24, 1998
Dysregulation of inflammatory cytokines in unrelated bone marrow transplantationA Nagler, A Bishara, C Brautbar, et al.The Annals of Otology, Rhinology, and Laryngology|August 26, 1998
Cytokine evaluation in throat infectionsE Deutsch, M Kaufman, B Nisman, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 1, 1995
Carboplatin and etoposide as first-line chemotherapy in advanced epithelial ovarian cancerD.Z. Edelmann, T. Peretz, V. Barak, et al.Leukemia & Lymphoma|August 1, 1992
Serum soluble interleukin-2 receptor levels are associated with clinical disease status and histopathological grade in non-Hodgkin's lymphoma and chronic lymphocytic leukemiaV Barak, M Ginzburg, I Kalickman, et al.Leukemia & Lymphoma|January 1, 1994
Soluble interleukin-2 receptor levels in cytomegalovirus disease and graft versus host disease after T-lymphocyte depleted bone marrow transplantation for hematological neoplasiasD Engelhard, A Nagler, R Singer, et al.Pageof 17